In the 250+ trials we’ve supported to date, CROs and ICLs have found our seamless process for Reader/Reviewer recruitment, contracting, and billing brings greater overall efficiency and reliability to clinical trial management.
Without the burden of slogging through Reader operations, you will be free to focus on improving your own offerings while reducing time and resource burdens.
We feature:
Lean, efficient, proactive processes
Quick, direct communication with leadership
Scalable based on your needs (size, timeline, protocols, methodologies, and more)
Resources and services beyond radiology: oncology, pathology, dermatology, cardiology, and many others
Acromegaly
Advanced Cancer(s)
Alveolar Proteinosis
Alzheimer’s Disease
Amyotrophic Lateral Sclerosis
Artificial Intelligence Software Validation
Beta-Sarcoglycan Deficiency
Beta-Thalassemia
Biliary Tract Cancer
Bladder Cancer
Brain Cancer
Brain Hemorrhage
Brain Metastases
Breast Cancer
Cachexia
Cervical Cancer
Chondrosarcoma
Chronic Lymphocytic Leukemia
Colorectal Cancer
Consulting
COPD
Covid-19
Crohn’s Disease
Devices
Diabetes
Diffuse Large B-Cell Lymphoma
Endometrial Cancer
Endometriosis
Epithelial Cancer
Erdheim-Chester Disease
Esophageal Cancer
Esophageal Squamous Cell Carcinoma
Familial Hypercholesterolemia
Friedreich’s Ataxia
Gastric Cancer
Gastroesophageal Junction
Gastrointestinal Cancer
Genitourinary Cancer
Giant Cell Arteritis
Glioblastoma
Glioma
Gout
Head & Neck Cancer
Hepatocellular Carcinoma
Idiopathic Pulmonary Fibrosis
Indolent Non-Hodgkin’s Lymphoma
Interstitial Lung Disease
Langerhans Cell Histiocytosis
Lung Cancer
Lung Nodules
Lymphoma
Mantle Cell Lymphoma
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplasia
Myelofibrosis
Myeloid Leukemia
Nasal Polyposis
NASH
Nasopharyngeal Cancer
Neuroblastoma
Neuroendocrine Tumors
Non-Hodgkin’s Lymphoma
Non-Small Cell Lung Cancer
Osteogenic Sarcoma
Ovarian Cancer
Pancreatic Cancer
Polycythemia Vera
Post-Myocardial Infarction
Primary Sclerosing Cholangitis
Prostate Cancer
Pulmonary Fibrosis
Refractory Large B-Cell Lymphoma
Renal Cell Carcinoma
Rheumatoid Arthritis
Rhinosinusitis
Sarcoidosis
Sarcoma
Small Cell Lung Cancer
Sickle Cell Disease
Small Lymphocytic Lymphoma
Solid Tumor
Squamous Cell Carcinoma
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Synovial Sarcoma
Systemic Lupus Erythematosus
Thyroid Cancer
Ulcerative Colitis
Urothelial Cancer
Vascular Thrombosis
Vestibular Schwannoma
Waldenstrom
Wilson’s Disease
ARIAATS-2018
BMD
Bone Age
BRIXIA
Cheson
Choi
Deauville
EASL
ECHO
ENDO_STAGE MRI Classification
EOR
EWT
GGO
Hallek
IMWG
INRC
iPCNSL
iRANO
iRECIST
Iron Content Assessment
irRC
irRECIST
iwCLL 2008
iwCLL 2018
IWG 2007
IWWM
Likert Scale
Lugano
Lumen Measurement
Lund-Mackay
Lung Nodule Identification
LYRIC
MacDonald
Mayo Scoring System
Metastatic Prostate Disease Assessment
MOCART
mRANO
MRCP
mRECIST
Nasal Polyp Score
NCCN Guidelines
Oncology Review
Owen 2013
Pathology Review
PCWG-2
PCWG-3
PERCIST
PET
PSMA
RAMRIS
RANO
RECIL
RECIST 1.0
RECIST 1.1
SES-CD
Sharp
SPARCC
T-Scores
Vasculitis Scoring
Volumetric Review
WHO
WORMS
Z-Scores
Zinreich Sinus Score
Bone Scan
Brain Scan
Cardiac PET
Cardiac MR
Colonoscopy
CT
DXA
Echocardiography
EEG
Endoscopy
FDG PET
HRCT
MRI
Nasal Endoscopy
Pathology
Medical Photography
SPECT
Transcranial Doppler Imaging
Ultrasound
Digital X-ray
It can be daunting– identifying, vetting, contracting, and managing imaging readers for clinical trials can lead to resource burdens and frustrating delays.
Our tried-and-true process replaces expensive ordeals with streamlined journeys.
By constantly building and refining our international, multi-specialty reviewer network, we meet your trial needs across a spectrum of requirements; we find the right experts for the most nuanced scientific asks.
With Radmetrix efficiently providing the right readers for your trials, your trial management team reclaims valuable time, time that enables you to focus on what matters most– designing, conducting, and advancing clinical research.